BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 12712487)

  • 1. Hypersensitivity and idiosyncratic reactions to oxaliplatin.
    Thomas RR; Quinn MG; Schuler B; Grem JL
    Cancer; 2003 May; 97(9):2301-7. PubMed ID: 12712487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features of hypersensitivity reactions to oxaliplatin: a 10-year experience.
    Polyzos A; Tsavaris N; Gogas H; Souglakos J; Vambakas L; Vardakas N; Polyzos K; Tsigris C; Mantas D; Papachristodoulou A; Nikiteas N; Karavokyros JG; Felekouras E; Griniatsos J; Giannopoulos A; Kouraklis G
    Oncology; 2009; 76(1):36-41. PubMed ID: 19033714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypersensitivity reactions to oxaliplatin in two asian patients.
    Ng CV
    Ann Pharmacother; 2005 Jun; 39(6):1114-8. PubMed ID: 15886290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxaliplatin may induce cytokine-release syndrome in colorectal cancer patients.
    Tonini G; Santini D; Vincenzi B; Borzomati D; Dicuonzo G; La Cesa A; Onori N; Coppola R
    J Biol Regul Homeost Agents; 2002; 16(2):105-9. PubMed ID: 12144121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of allergic reactions to oxaliplatin in colorectal cancer patients.
    Suenaga M; Mizunuma N; Shinozaki E; Matsusaka S; Chin K; Muto T; Konishi F; Hatake K
    J Support Oncol; 2008; 6(8):373-8. PubMed ID: 19149322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypersensitivity reactions to oxaliplatin and the application of a desensitization protocol.
    Gammon D; Bhargava P; McCormick MJ
    Oncologist; 2004; 9(5):546-9. PubMed ID: 15477639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxaliplatin-associated hypersensitivity reactions: clinical presentation and management.
    Hewitt MR; Sun W
    Clin Colorectal Cancer; 2006 Jul; 6(2):114-7. PubMed ID: 16945166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypersensitivity to oxaliplatin: an investigation of incidence and risk factors, and literature review.
    Kim BH; Bradley T; Tai J; Budman DR
    Oncology; 2009; 76(4):231-8. PubMed ID: 19246947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rechallenge with cisplatin in a patient with pancreatic cancer who developed a hypersensitivity reaction to oxaliplatin. Is skin test useful in this setting?
    Elligers KT; Davies M; Sanchis D; Ferencz T; Saif MW
    JOP; 2008 Mar; 9(2):197-202. PubMed ID: 18326929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fever as the only manifestation of hypersensitivity reactions associated with oxaliplatin in a patient with colorectal cancer Oxaliplatin-induced hypersensitivity reaction.
    Saif M; Roy S; Ledbetter L; Madison J; Syrigos K
    World J Gastroenterol; 2007 Oct; 13(39):5277-81. PubMed ID: 17876901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re-challenging patients with oxaliplatin allergy: the successful use of a standardised pre-medication protocol in a single institute.
    Siu SW; Chan WL; Liu KY; Choy TS; Leung TW; Au KH
    Clin Oncol (R Coll Radiol); 2011 Oct; 23(8):558-9. PubMed ID: 21524570
    [No Abstract]   [Full Text] [Related]  

  • 12. Desensitization to oxaliplatin with two stages of premedication in a patient with metastatic rectal cancer.
    Nozawa H; Muto Y; Yamada Y
    Clin Ther; 2008 Jun; 30(6):1160-5. PubMed ID: 18640472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful desensitization to oxaliplatin.
    Mis L; Fernando NH; Hurwitz HI; Morse MA
    Ann Pharmacother; 2005 May; 39(5):966-9. PubMed ID: 15784807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A single-arm Phase II validation study of preventing oxaliplatin-induced hypersensitivity reactions by dexamethasone: the AVOID trial.
    Yoshida Y; Hirata K; Matsuoka H; Iwamoto S; Kotaka M; Fujita H; Aisu N; Hoshino S; Kosaka T; Maeda K; Kiyomi F; Yamashita Y
    Drug Des Devel Ther; 2015; 9():6067-73. PubMed ID: 26648694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Standardization of skin tests for diagnosis and prevention of hypersensitivity reactions to oxaliplatin.
    Pagani M; Bonadonna P; Senna GE; Antico A
    Int Arch Allergy Immunol; 2008; 145(1):54-7. PubMed ID: 17703101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variant hypersensitivity reaction (HSR) presented with persistent dry cough after receiving oxaliplatin in a pancreatic cancer patient.
    Li J; Peccerillo J; Kaley K; Saif MW
    Iran J Allergy Asthma Immunol; 2009 Sep; 8(3):165-8. PubMed ID: 20124609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypersensitivity Reactions to oxaliplatin: incidence and management.
    Gowda A; Goel R; Berdzik J; Leichman CG; Javle M
    Oncology (Williston Park); 2004 Nov; 18(13):1671-5; discussion 1676, 1680, 1683-4. PubMed ID: 15648298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypersensitivity reactions to oxaliplatin: what nurses need to know.
    Bonosky K; Miller R
    Clin J Oncol Nurs; 2005 Jun; 9(3):325-30. PubMed ID: 15973843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allergic-type reactions to oxaliplatin: retrospective analysis of 42 patients.
    Maindrault-Goebel F; André T; Tournigand C; Louvet C; Perez-Staub N; Zeghib N; De Gramont A
    Eur J Cancer; 2005 Oct; 41(15):2262-7. PubMed ID: 16154353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxaliplatin hypersensitivity: case report and successful repeat desensitization.
    Edmondson DA; Gruling BJ; Urmanski AM; Wong SJ; Levy MB
    Am J Ther; 2007; 14(1):116-8. PubMed ID: 17303980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.